1 / 20

Treatment Management of Rheumatoid Arthritis

Treatment Management of Rheumatoid Arthritis. Findings and In Depth Analysis. Patients load and monthly work averages. Findings and In Depth Analysis. Rheumatologists Monthly Work Load KSA. 75. 12. 15. 6. 238. Understanding RA. Findings and In Depth Analysis.

kamal-warner
Download Presentation

Treatment Management of Rheumatoid Arthritis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Treatment Management of Rheumatoid Arthritis

  2. Findings and In Depth Analysis

  3. Patients load and monthly work averages Findings and In Depth Analysis

  4. Rheumatologists Monthly Work LoadKSA 75 12 15 6 238

  5. Understanding RA Findings and In Depth Analysis

  6. Rating of Importance of Criteria used to classify Disease Severity (Analysis Used top 2 boxes percentages - KSA) (n=30)

  7. The most preferred tool used for the Disease Evaluation (KSA) ACR criteria score is the most preferred diagnostic tool, followed by the DAS and the blood tests respectively. These tools are described as practical, accurate and of international use.

  8. Reasons for choosing each criteria as the most suitable (KSA) ACR, N=9 DAS, N=5 CPR/ESR/ Anti CCP, N=4

  9. Objectives in the management of RA patients (First mentioned KSA) Improving patient’s quality of life and reliving the pain are the main objectives of the management of RA patients

  10. Other mentioned objectives in the management of RA patients (KSA) Again, Improving patient’s quality of life and reliving the pain are the objectives of the management of RA patients mentioned by most of the physicians

  11. Factors that encourage the physicians to prescribe biological treatment to RA patients (KSA) 56% of the respondents would prescribe the biologics because of their efficacy. 49% of the physicians use them as second or third line after failure of the DMARDs

  12. Barriers holding the doctors from prescribing biologicals to their RA patients (KSA) All the respondents face the problem of the cost and/or availability of the biologics when they want to prescribe them to their RA patients

  13. Treatment Algorithm for the moderate to severe Rheumatoid Arthritis First Line In 12% of the cases, physicians could switch from one of the products, mainly from NSAIDs for the first line to Hydroxychloroquine or Steroids In most of the cases, physicians add Hydroxychloroquine or Steroids to the products for the first line MTX + NSAIDs MTX or NSAID + HQ or Steroid MTX + NSAIDs + HQ or Steroids Second Line Sometimes, physicians switch from the second line therapy to the biologics and they use them as monotherapy in third line More often, the biologics are added to the MTX containing regimens and they are used in combination in third line therapy Adding another medication is always due to the inadequate response to the previous one. Physicians take also into consideration the ability of the patient to afford the combination. Reasons for switching to another medication are in 100% of the cases the inadequate response to the previous one. Biologics Biologics + MTX based therapy Third Line NSAIDs/Steroids are not used as a chronic therapy, they are stopped after stabilization of the patients' condition and they are reintroduced upon disease flares

  14. Treatment Algorithm and duration of therapy (KSA) (n=30)

  15. Average Lapse of Time between RA Diagnosis and the introduction of different therapeutic classes (KSA) 100% • Some physicians in KSA have started to prescribe biologicals as first line therapy once the diagnosis is confirmed. Others reserve it for third line therapy. (n=30)

  16. Treatment guidelines followed in the management of moderate to severe RA patients (KSA) The ACR guidelines are the only treatment protocol followed by the physicians.

  17. Referral vs. diagnosis of RA (KSA) Specialties of the referring doctors

  18. Treatment Shares and Patterns Findings and In Depth Analysis

  19. Overall Prescription Shares of different therapeutic classes used in the treatment of Rheumatoid Arthritis (KSA) (n=30) DMARDs are prescribed to almost 90%Patients with RA, followed by NSAIDs Biologics are prescribed to 21% of the RA patients in KSA

  20. Split of 100 biologics prescriptions according to the previous therapy (KSA) Out of each 100 prescriptions of Biologics, 43 are given to patients having DMARDs + NSAIDs (with or without Steroids) and another 22% to patients having 1 DMARDs with or without Steroids (n=30) 100%

More Related